Literature DB >> 27837456

Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile.

Tobias Ettl1, Matthias Hautmann2, Torsten E Reichert1, Richard Bauer3,4.   

Abstract

The expression of the hair follicle stem cell marker CD34 was analyzed in five different head and neck squamous cell carcinoma (HNSCC) cell lines with different antibodies. All HNSCC cell lines expressed CD34 on their cell surface. After cell cycle synchronization via serum starvation, we observed cyclic CD34 expression in HNSCC cells dependent on cell cycle progression via immunofluorescent staining and flow cytometric analysis. Investigation of the CD34(+) and CD34(-) HNSCC populations revealed most of the cells in S-phase and G2/M-Phase in CD34(+) cells in contrast to CD34(-) cells. Knockdown of CD34 in HNSCC cells led to diminished clonal expansion in a colony forming assay after subjecting the cells to ionizing radiation. Furthermore, knockdown of CD34 after cell cycle synchronization induced high CK1, CK4, and CK5 gene expression and downregulation of CK10 gene expression as shown by Taqman® quantitative PCR analysis. The expression levels of CK1 and CK10 were verified via western blot analysis. In summary, our study shows that CD34 plays a role during cell cycle progression of head and neck squamous cell carcinoma and additionally is involved in irradiation resistance and differentiation of malignant oral keratinocytes.

Entities:  

Keywords:  CD34; Cell cycle; Differentiation; Head and neck squamous cell carcinoma; Keratinocyte; Oral squamous cell carcinoma; Stem cell marker

Mesh:

Substances:

Year:  2016        PMID: 27837456     DOI: 10.1007/s10238-016-0440-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  37 in total

Review 1.  'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments.

Authors:  Pierre A Coulombe; M Bishr Omary
Journal:  Curr Opin Cell Biol       Date:  2002-02       Impact factor: 8.382

2.  Characterization and isolation of stem cell-enriched human hair follicle bulge cells.

Authors:  Manabu Ohyama; Atsushi Terunuma; Christine L Tock; Michael F Radonovich; Cynthia A Pise-Masison; Steven B Hopping; John N Brady; Mark C Udey; Jonathan C Vogel
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  CD34 expression in desmoplastic melanoma.

Authors:  M P Hoang; M A Selim; R C Bentley; J L Burchette; C R Shea
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

4.  Cancer stem cells: targets and potential biomarkers for radiotherapy.

Authors:  Mechthild Krause; Ala Yaromina; Wolfgang Eicheler; Ulrike Koch; Michael Baumann
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

Review 5.  Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.

Authors:  Frank Pajonk; Erina Vlashi; William H McBride
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

6.  Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34.

Authors:  Carol S Trempus; Rebecca J Morris; Carl D Bortner; George Cotsarelis; Randall S Faircloth; Jeffrey M Reece; Raymond W Tennant
Journal:  J Invest Dermatol       Date:  2003-04       Impact factor: 8.551

7.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

8.  CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.

Authors:  T T Kirchmann; V G Prieto; B R Smoller
Journal:  Arch Dermatol       Date:  1994-05

9.  Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells.

Authors:  D S Krause; T Ito; M J Fackler; O M Smith; M I Collector; S J Sharkis; W S May
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

10.  Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.

Authors:  A S Pak; M A Wright; J P Matthews; S L Collins; G J Petruzzelli; M R Young
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.